Abstract
Here we profile the Guangzhou Institute of Biomedicine and
Health (GIBH), which was created to improve public health by promoting
technology-driven innovation and international collaboration in biomedical
research. GIBH is designed to be a
“translational highway from bench to clinic”, focusing on the early stages of
pharmaceutical discovery and development and partnering with other entities to
bring lab discoveries to the clinic.
Cell Notes 16, 20–21.
Michele Arduengo
Promega Corporation
Publication Date: 2006